CSL Limited (CSLLY)
OTCMKTS
· Delayed Price · Currency is USD
89.30
+0.57 (0.64%)
Nov 21, 2024, 4:00 PM EST
CSL Limited Employees
CSL Limited had 32,698 employees as of June 30, 2024. The number of employees increased by 633 or 1.97% compared to the previous year.
Employees
32,698
Change (1Y)
633
Growth (1Y)
1.97%
Revenue / Employee
$452,627
Profits / Employee
$80,800
Market Cap
87.17B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sandoz Group AG | 22,633 |
| Telix Pharmaceuticals Limited | 234 |
| Elekta AB (publ) | 4,718 |
| Ryman Healthcare Limited | 7,700 |
| Verano Holdings Corp. | 3,900 |
| Vireo Growth Inc. | 490 |
| Medexus Pharmaceuticals Inc. | 82 |
CSL Limited News
- 4 weeks ago - New Data Presented at IDWeek 2024 Show Adjuvanted and High-Dose Influenza Vaccines are Comparable in Protecting Adults 65 Years of Age and Older Against Seasonal Influenza - PRNewsWire
- 5 weeks ago - CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy - PRNewsWire
- 5 weeks ago - CSL Seqirus Presents Data at IDWeek 2024 Highlighting the Urgent Need to Increase Influenza Vaccination Rates and the Benefits of Cell-Based Influenza Vaccines - PRNewsWire
- 6 weeks ago - GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report - Benzinga
- 6 weeks ago - CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Sixth BARDA Award in Response to Avian Influenza - PRNewsWire
- 6 weeks ago - Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply - BNN Bloomberg
- 7 weeks ago - CSL Seqirus Presents Real-World Evidence at OPTIONS XII Conference Highlighting Effectiveness of Influenza Vaccinations - PRNewsWire
- 7 weeks ago - Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination - Business Wire